ethylnitrosourea has been researched along with Local Neoplasm Recurrence in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alomran, R; Brown, JM; Chernikova, SB; Jang, T; Klussmann, S; Kruschinski, A; Lartey, F; Liu, SC; Merchant, M; Recht, L; Stafford, J; Zboralski, D; Zöllner, S | 1 |
Kwiatkowski, D; Lane, H; Malinowska-Kolodziej, I; Pollizzi, K; Stumm, M | 1 |
Albain, KS; Crowley, JJ; Gandara, D; Griffin, B; Hutchins, L; Livingston, RB; O'Bryan, RM; Von Hoff, DD | 1 |
1 trial(s) available for ethylnitrosourea and Local Neoplasm Recurrence
Article | Year |
---|---|
Predictors of survival following relapse or progression of small cell lung cancer. Southwest Oncology Group Study 8605 report and analysis of recurrent disease data base.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Ethylnitrosourea; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Survival Rate; Thiotepa; Vincristine | 1993 |
2 other study(ies) available for ethylnitrosourea and Local Neoplasm Recurrence
Article | Year |
---|---|
Blockade of SDF-1 after irradiation inhibits tumor recurrences of autochthonous brain tumors in rats.
Topics: Alkylating Agents; Animals; Brain Neoplasms; Cell Proliferation; Cells, Cultured; Chemokine CXCL12; Ethylnitrosourea; Human Umbilical Vein Endothelial Cells; Humans; Magnetic Resonance Imaging; Mice; Neoplasm Recurrence, Local; Oligonucleotides, Antisense; Rats; Rats, Sprague-Dawley; Receptors, CXCR; Receptors, CXCR4; Survival Rate; X-Ray Therapy | 2014 |
Equivalent benefit of mTORC1 blockade and combined PI3K-mTOR blockade in a mouse model of tuberous sclerosis.
Topics: Animals; Antineoplastic Agents; Carrier Proteins; Disease Models, Animal; Ethylnitrosourea; Everolimus; Imidazoles; Kidney Neoplasms; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Inbred C57BL; Mice, Transgenic; Multiprotein Complexes; Neoplasm Recurrence, Local; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphotransferases (Alcohol Group Acceptor); Proteins; Quinolines; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Transcription Factors; Tuberous Sclerosis | 2009 |